<VariationArchive VariationID="1073047" VariationName="NM_024301.5(FKRP):c.511_523del (p.Leu171fs)" VariationType="Deletion" Accession="VCV001073047" Version="6" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-03-30" DateCreated="2021-05-10" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1064731" VariationID="1073047">
      <GeneList>
        <Gene Symbol="FKRP" FullName="fukutin related protein" GeneID="79147" HGNC_ID="HGNC:17997" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19q13.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="46744760" stop="46758575" display_start="46744760" display_stop="46758575" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="47249302" stop="47261831" display_start="47249302" display_stop="47261831" Strand="+" />
          </Location>
          <OMIM>606596</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_024301.5(FKRP):c.511_523del (p.Leu171fs)</Name>
      <CanonicalSPDI>NC_000019.10:46755957:GCCCTGAACGTCAGCC:GCC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19q13.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="46755958" stop="46755970" display_start="46755958" display_stop="46755970" variantLength="13" positionVCF="46755957" referenceAlleleVCF="GGCCCTGAACGTCA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="47259215" stop="47259227" display_start="47259215" display_stop="47259227" variantLength="13" positionVCF="47259214" referenceAlleleVCF="GGCCCTGAACGTCA" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>L171fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.46755961_46755973del" Assembly="GRCh38">
            <Expression>NC_000019.10:g.46755961_46755973del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.47259218_47259230del" Assembly="GRCh37">
            <Expression>NC_000019.9:g.47259218_47259230del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008898.2" sequenceAccession="NG_008898" sequenceVersion="2" change="g.14916_14928del">
            <Expression>NG_008898.2:g.14916_14928del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001039885.3" sequenceAccession="NM_001039885" sequenceVersion="3" change="c.511_523del">
            <Expression>NM_001039885.3:c.511_523del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001034974.1" sequenceAccession="NP_001034974" sequenceVersion="1" change="p.Leu171fs">
            <Expression>NP_001034974.1:p.Leu171fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_024301.5" sequenceAccession="NM_024301" sequenceVersion="5" change="c.511_523del" MANESelect="true">
            <Expression>NM_024301.5:c.511_523del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_077277.1" sequenceAccession="NP_077277" sequenceVersion="1" change="p.Leu171fs">
            <Expression>NP_077277.1:p.Leu171fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_761" sequenceAccession="LRG_761">
            <Expression>LRG_761:g.14916_14928del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_761t1" sequenceAccession="LRG_761t1">
            <Expression>LRG_761t1:c.511_523del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_761p1" sequenceAccession="LRG_761p1" change="p.Leu171fs">
            <Expression>LRG_761p1:p.Leu171fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1314297056" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_024301.5(FKRP):c.511_523del (p.Leu171fs) AND Walker-Warburg congenital muscular dystrophy" Accession="RCV001385930" Version="4">
        <ClassifiedConditionList TraitSetID="31131">
          <ClassifiedCondition DB="MedGen" ID="C0265221">Walker-Warburg congenital muscular dystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_024301.5(FKRP):c.511_523del (p.Leu171fs) AND Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5" Accession="RCV003463008" Version="1">
        <ClassifiedConditionList TraitSetID="1168">
          <ClassifiedCondition DB="MedGen" ID="C3150413">Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-06-27" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-01" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2021-05-10" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11592034</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12666124</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12707425</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">14742276</ID>
        </Citation>
        <DescriptionHistory Dated="2023-12-29">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="1168" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10061" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, FKRP-RELATED</ElementValue>
                <XRef Type="MIM" ID="613153" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A5</ElementValue>
                <XRef ID="Congenital+muscular+dystrophy-dystroglycanopathy+%28with+brain+and+eye+anomalies%29+type+A5/8068" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5</ElementValue>
                <XRef ID="MONDO:0013157" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5</ElementValue>
                <XRef Type="MIM" ID="613153" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606596.0017" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606596.0019" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606596.0016" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MDDGA5</ElementValue>
                <XRef Type="MIM" ID="613153" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15625" />
                <XRef ID="15625" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies (type A), which includes both the more severe Walker-Warburg syndrome (WWS) and the slightly less severe muscle-eye-brain disease (MEB), is an autosomal recessive disorder with characteristic brain and eye malformations, profound mental retardation, congenital muscular dystrophy, and death usually in the first years of life. It represents the most severe end of a phenotypic spectrum of similar disorders resulting from defective glycosylation of DAG1 (128239), collectively known as 'dystroglycanopathies' (Beltran-Valero de Bernabe et al., 2004).
For a general phenotypic description and a discussion of genetic heterogeneity of muscular dystrophy-dystroglycanopathy type A, see MDDGA1 (236670).</Attribute>
                <XRef Type="MIM" ID="613153" DB="OMIM" />
              </AttributeSet>
              <XRef ID="588" DB="Orphanet" />
              <XRef ID="899" DB="Orphanet" />
              <XRef ID="C3150413" DB="MedGen" />
              <XRef ID="MONDO:0013157" DB="MONDO" />
              <XRef Type="MIM" ID="613153" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="31131" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="35635" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy-dystroglycanopathy, type A</ElementValue>
                <XRef ID="MONDO:0000171" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS236670" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Walker-Warburg syndrome</ElementValue>
                <XRef ID="899" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Walker-Warburg congenital muscular dystrophy</ElementValue>
                <XRef ID="Walker-Warburg+syndrome/7436" DB="Genetic Alliance" />
                <XRef ID="111504002" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2599" />
                <XRef ID="2599" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="899" DB="Orphanet" />
              <XRef ID="C0265221" DB="MedGen" />
              <XRef ID="MONDO:0000171" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS236670" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7843892" SubmissionDate="2023-12-07" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_024301.5:c.511_523del|OMIM:613153" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004197419" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_024301.5:c.511_523del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613153" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3111596" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="10912249|MedGen:C0265221" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001585950" DateUpdated="2024-02-28" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11592034</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12666124</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12707425</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14742276</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Leu171Cysfs*64) in the FKRP gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 325 amino acid(s) of the FKRP protein. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with FKRP-related conditions. ClinVar contains an entry for this variant (Variation ID: 1073047). This variant disrupts a region of the FKRP protein in which other variant(s) (p.Ser385*) have been determined to be pathogenic (PMID: 11592034, 12666124, 12707425, 14742276). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FKRP" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.47259215_47259227del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0265221" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3111596" TraitType="Disease" MappingType="XRef" MappingValue="C0265221" MappingRef="MedGen">
        <MedGen CUI="C0265221" Name="Walker-Warburg congenital muscular dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7843892" TraitType="Disease" MappingType="XRef" MappingValue="613153" MappingRef="OMIM">
        <MedGen CUI="C3150413" Name="Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

